• Vitamins and Minerals, Sodium Phosphate
    Dosage form: Tablet
    Strength: Tablet (monobasic & dibasic): 1.5g
    Indications/Special comments: Treatment and prevention of hypophosphatemia
    Dosage Administration: See package insert
    View full drug info
  • Vitamins and Minerals, Selenium
    Dosage form: Injection
    Strength: 40mcg/ml
    Indications/Special comments: Selenium Injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN). Administration of selenium in TPN solutions helps to maintain plasma selenium levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
    Dosage Administration: Selenium deficiency: By intramuscular injection, or by intravenous injection: Adult 100 – 500 micrograms daily.
    View full drug info
  • Topical Anti-infectives, Sodium Fusidate
    Dosage form: Ointment
    Strength: 0.02
    Indications/Special comments: For staphylococcal infections
    Dosage Administration: Apply 3 - 4 times daily.
    View full drug info
  • Topical Anti-infectives, Silver Sulphadiazine
    Dosage form: Cream
    Strength: 1%, in 400g & 20g
    Indications/Special comments: Prophylaxis and treatment of infection in burns
    Dosage Administration: Apply using aseptic technique daily (more frequently if volume of exudate is large) whilst there is a possibility of infection, or until healing is complete.
    View full drug info
  • Respiratory Drugs, Sodium Cromoglycate
    Dosage form: Solution
    Strength: 20mg/2ml
    Indications/Special comments: Indicated as a prophylaxis in the management of bronchial asthma in patients who require continuing symptomatic relief. It has no role in the treatment of an acute attack of asthma, especially status asthmaticus, because it has no intrinsic bronchodilating activity. It is also indicated to prevent bronchospasm induced by exercise or by exposure to allergens, cold dry air, environmental pollutants, or other known precipitating factors when exposure is either episodic or continuous.
    Dosage Administration: Oral inhalation: 20mg (1 capsule) as a single dose just prior to exposure to the precipitating factor; or, if used chronically, 20mg (1 capsule) four times a day at regular intervals, the dosage being adjusted as needed and tolerated. Child up to 2 years of age: The capsule for inhalation should not be used.
    View full drug info
  • Respiratory Drugs, Salmeterol
    Dosage form: Inhaler
    Strength: 50mcg
    Indications/Special comments: Asthma/Bronchospasm: Treatment of asthma and the prevention of bronchospasm (only as concomitant therapy with a long-term asthma control medication, such as an inhaled corticosteroid), in patients 4 years and older with reversible obstructive airway disease, including patients with symptoms of nocturnal asthma. Chronic obstructive pulmonary disease: Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) (including emphysema and chronic bronchitis). Exercise-induced bronchospasm: Prevention of exercise-induced bronchospasm (EIB) in patients 4 years and older (monotherapy may be indicated in patients without persistent asthma). Limitations of use: Salmeterol is not indicated for the relief of acute bronchospasm.
    Dosage Administration: Asthma/Bronchospasm (maintenance and prevention): Children =4 years, Adolescents, and Adults: Inhalation: One inhalation twice daily (~12 hours apart); maximum: 1 inhalation twice daily. Note: For asthma control, long acting beta2-agonists (LABAs) should be used in combination with inhaled corticosteroids and not as monotherapy.frequent or chronic use of LABAs for exercise-induced bronchospasm is discouraged by the Asthma Guidelines (NAEPP, 2007).COPD (maintenance): Adults: Inhalation: One inhalation twice daily (~12 hours apart); maximum: 1 inhalation twice daily.
    View full drug info
  • Respiratory Drugs, Salbutamol (Albuterol)
    Dosage form: Tablet
    Strength: 4mg
    Indications/Special comments: Asthma and other conditions associated with reversible airways obstruction
    Dosage Administration: Oral: Adult: 2 to 6mg (base) - three or four times a day initially, the dosage being increased and tolerated up to a maximum of 8 mg four times a day.Child (6 - 12 years): 2mg (base) - three or four times a day initially, the dosage being increased and tolerated up to a maximum of 24mg per day in divided doses.
    View full drug info
  • Respiratory Drugs, Salbutamol (Albuterol)
    Dosage form: Syrup
    Strength: 0.4mg/ml
    Indications/Special comments: Asthma and other conditions associated with reversible airways obstruction
    Dosage Administration: Oral: Adult: 2 to 6 mg (base) three or four times a day initially, the dosage being increased as needed and tolerated up to a maximum of 8mg four times a day. Child (2 – 6 years): 0.1 mg (base) per kg of body weight three times a day initially, the dosage being increased as needed and tolerated up to 0.2 mg per kg of body weight, not to exceed 4mg three times a day. Child (6 - 14 years): 2mg (base) three or four times a day initially, the dosage being increased as needed and tolerated up to a maximum of 24mg per day in divided doses.
    View full drug info
  • Respiratory Drugs, Salbutamol (Albuterol)
    Dosage form: Nebulizer Solution
    Strength: 0.5% in 20ml
    Indications/Special comments: Asthma and other conditions associated with reversible airways obstruction
    Dosage Administration: By inhalation of nebulised solution: Adult: 2.5–5 mg, repeated up to 4 times daily or more frequently in severe cases
    View full drug info
  • Respiratory Drugs, Salbutamol (Albuterol)
    Dosage form: Inhaler
    Strength: 0.083% in 3ml
    Indications/Special comments: Asthma and other conditions associated with reversible airways obstruction
    Dosage Administration: Inhalation (aerosol) - Oral inhalation: Adult: 0.18 to 0.2mg (1 - 2 inhalations/puffs) every four to six hours as required.
    View full drug info